Current Urology Reports最新文献_第2页

Functional Outcomes of Orthotopic Neobladder in Women. 女性矫形新膀胱的功能结果。

IF 2.5 2区医学

Current Urology Reports Pub Date : 2024-11-01 Epub Date: 2024-08-28 DOI: 10.1007/s11934-024-01223-7

Unwanaobong Nseyo, David Ginsberg

{"title":"Functional Outcomes of Orthotopic Neobladder in Women.","authors":"Unwanaobong Nseyo, David Ginsberg","doi":"10.1007/s11934-024-01223-7","DOIUrl":"10.1007/s11934-024-01223-7","url":null,"abstract":"Purpose of review: This review paper summarizes the available literature on the evolution of surgical approach to radical cystectomy in female bladder cancer patients and its impact on functional outcomes in orthotopic neobladder.Recent findings: Traditionally, radical cystectomy in female bladder cancer patients has been maximally extirpative with pelvic exenteration. Recently, new techniques which include pelvic organ-sparing, nerve-sparing and vaginal-sparing have demonstrated improved rates of urinary incontinence and retention. Additional techniques include prophylactic apical suspension which reduces the likelihood of pelvic organ prolapse, a risk factor for voiding dysfunction in the setting of orthotopic neobladder. Surgical management of bladder cancer in female patients has evolved to include surgical approaches which center quality of life and functional outcomes that are unique to female patients who have undergone radical cystectomy with ileal neobladder and can be optimized based on considerations regarding an approach that limits pelvic floor and pelvic nerve disruption.","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"277-285"},"PeriodicalIF":2.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366725/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142092520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Telemedicine in Endourology for Patient Management and Healthcare Delivery: Current Status and Future Perspectives. 远程医疗在腔内泌尿学中用于患者管理和医疗服务：现状与未来展望》。

IF 2.5 2区医学

Current Urology Reports Pub Date : 2024-11-01 Epub Date: 2024-07-09 DOI: 10.1007/s11934-024-01224-6

Ali Talyshinskii, Nithesh Naik, B M Zeeshan Hameed, Gafour Khairley, Princy Randhawa, Bhaskar Kumar Somani

{"title":"Telemedicine in Endourology for Patient Management and Healthcare Delivery: Current Status and Future Perspectives.","authors":"Ali Talyshinskii, Nithesh Naik, B M Zeeshan Hameed, Gafour Khairley, Princy Randhawa, Bhaskar Kumar Somani","doi":"10.1007/s11934-024-01224-6","DOIUrl":"10.1007/s11934-024-01224-6","url":null,"abstract":"Purpose of review: Researchers have examined how telemedicine affects endourological patients. This review analyzes the literature to determine telemedicine's benefits and limitations in endourology.Recent findings: Many studies were devoted to describing the effect of telemedicine on endourological patient satisfaction, optimization of the clinical decision-making among patients with kidney and ureteric stones, the effectiveness of telemedicine in the management of patients with indications for PCNL, follow-up for patients with urolithiasis and describing financial effectiveness for the patients after BOO surgery. The authors describe phone calls, video calls, and online booking platforms as used as telemedicine technology. However, several concerns also exist, such as the necessity of internet connections and appropriate devices, different receptivity among certain subgroups, data safety, and different regulatory environments among countries. Telemedicine offers the potential to reduce patient travel time, expedite decision-making, and save costs in endourology. However, its everyday implementation is challenging due to various obstacles faced by patients and providers, hindering the realization of its full potential and necessitating a systematic approach to problem-solving.","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":" ","pages":"299-310"},"PeriodicalIF":2.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141558355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Current and Future Directions of Technology in Assessment of Peyronie's Disease. 评估佩罗尼氏病的当前和未来技术发展方向。

IF 2.5 2区医学

Current Urology Reports Pub Date : 2024-10-29 DOI: 10.1007/s11934-024-01247-z

Abrar H Mian, Matthew J Ziegelmann

{"title":"Current and Future Directions of Technology in Assessment of Peyronie's Disease.","authors":"Abrar H Mian, Matthew J Ziegelmann","doi":"10.1007/s11934-024-01247-z","DOIUrl":"10.1007/s11934-024-01247-z","url":null,"abstract":"Purpose of review: This review assesses the effectiveness of various imaging modalities for diagnosing and managing Peyronie's disease (PD), exploring their clinical utility and limitations.Recent findings: Ultrasonography, currently the only modality endorsed by the American Urological Association, effectively detects calcifications and assesses vascular status but struggles with identifying non-palpable plaques. Computed tomography and magnetic resonance imaging provide detailed anatomical views but are costly along with other deterring factors. Autophotography and 3-dimensional imaging offer convenient home assessments but with variable accuracy. Elastography improves upon traditional ultrasonography, while emerging AI technologies show promise for automating precise curvature assessments, pending further validation. A combined approach tailored to each individual patient based on their needs enhances diagnostic accuracy. Supplementing ultrasonography with elastography and potentially AI could improve diagnostic outcomes and better guide treatment decisions. Continued research is vital to integrate these advancements into standard clinical practice and develop updated standardized protocols.","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"15"},"PeriodicalIF":2.5,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142544310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Intersection of Artificial Intelligence, Wearable Devices, and Sexual Medicine. 人工智能、可穿戴设备和性医学的交叉点。

IF 2.5 2区医学

Current Urology Reports Pub Date : 2024-10-11 DOI: 10.1007/s11934-024-01244-2

Dayna R Smerina, Amy M Pearlman

引用次数: 0

Strategies to Improve Clinical Outcomes and Patient Experience Undergoing Transurethral Resection of Bladder Tumor. 改善经尿道膀胱肿瘤切除术临床效果和患者体验的策略。

IF 2.5 2区医学

Current Urology Reports Pub Date : 2024-10-11 DOI: 10.1007/s11934-024-01243-3

Sadra Sepehri, Michael E Rezaee, Zhuo Tony Su, Max Kates

{"title":"Strategies to Improve Clinical Outcomes and Patient Experience Undergoing Transurethral Resection of Bladder Tumor.","authors":"Sadra Sepehri, Michael E Rezaee, Zhuo Tony Su, Max Kates","doi":"10.1007/s11934-024-01243-3","DOIUrl":"https://doi.org/10.1007/s11934-024-01243-3","url":null,"abstract":"Purpose of review: To describe patient experiences of transurethral resection of bladder tumor (TURBT) and review recent advances in enhancing clinical outcomes.Recent findings: High rates of recurrence and progression of non-muscle invasive bladder tumors expose patients to multiple TURBT procedures throughout their disease process. Understanding the impact of TURBT on quality of life and patient experiences is crucial for shared decision-making, thus enhanced recovery protocol trials are being explored to improve patient outcomes. The variability in TURBT practices worldwide contributes to differing bladder tumor recurrence rates, prompting efforts to standardize practices by evaluating the impact of patient, hospital, and surgeon factors. For select cases, less intensive surveillance regimens have reduced toxicities and costs without compromising oncologic outcomes. New innovative approaches such as en bloc- and stratified resection techniques may reduce perioperative complications and improve clinical outcomes. Finally, neoadjuvant and ablative treatments have shown to be promising alternatives to TURBT, necessitating further investigation in this setting. TURBT is essential for diagnosing and treating bladder cancer. Reducing associated morbidities and improving surgical outcomes involve multifaceted approaches, including standardizing surgical practices, exploring innovative techniques, and optimizing surveillance regimens, all while promoting patient quality of life. Neoadjuvant therapies as alternative treatments are on the horizon and may ultimately change the landscape of bladder cancer care.","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"13"},"PeriodicalIF":2.5,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142399704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Impact of DNA Repair Deficiency in the Evolving Treatment Landscape of Bladder Cancer. DNA 修复缺陷在不断变化的膀胱癌治疗中的影响。

IF 2.5 2区医学

Current Urology Reports Pub Date : 2024-10-09 DOI: 10.1007/s11934-024-01242-4

Vincent D D'Andrea, Christopher J Magnani, John Ernandez, Joaquim Bellmunt, Matthew Mossanen, Timothy N Clinton, Filipe L F Carvalho, Kent W Mouw

{"title":"Impact of DNA Repair Deficiency in the Evolving Treatment Landscape of Bladder Cancer.","authors":"Vincent D D'Andrea, Christopher J Magnani, John Ernandez, Joaquim Bellmunt, Matthew Mossanen, Timothy N Clinton, Filipe L F Carvalho, Kent W Mouw","doi":"10.1007/s11934-024-01242-4","DOIUrl":"https://doi.org/10.1007/s11934-024-01242-4","url":null,"abstract":"Purpose of review: This review explores the current landscape of treatments which target the DNA damage response (DDR) in metastatic and muscle-invasive bladder cancer. It emphasizes recent clinical trials which integrate DDR inhibitors with standard chemotherapy and immunotherapy.Recent findings: Noteworthy findings include the ATLANTIS trial, which demonstrated prolonged progression-free survival (PFS) in DDR biomarker-selected patients using PARP inhibitors as maintenance after standard chemotherapy. Trials such as BAYOU, which combined immunotherapy with PARP inhibition, similarly suggested a potential therapeutic benefit in DDR biomarker-selected patients with bladder cancer. Efforts to develop bladder-sparing treatment regimens based on DDR-associated mutational profiles, such as the RETAIN and HCRN 16-257 trials, have had mixed outcomes to date. There are now ongoing efforts to combine DDR inhibitors with the newest bladder cancer therapies, such as antibody-drug conjugates. This review highlights the most recent advances in targeting DNA repair deficiency in the evolving treatment landscape of bladder cancer.","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"12"},"PeriodicalIF":2.5,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical Implications of the Molecular and Genomic Landscape of Upper Tract Urothelial Carcinoma. 上尿路上皮癌的分子和基因组图谱对临床的影响

IF 2.5 2区医学

Current Urology Reports Pub Date : 2024-10-08 DOI: 10.1007/s11934-024-01245-1

Salvador Jaime-Casas, Abhishek Tripathi, Sumanta K Pal, Wesley Yip

引用次数: 0

Rapid Lifestyle Recommendations to Improve Urologic, Heart and Overall Health. 改善泌尿系统、心脏和整体健康的快速生活方式建议。

IF 2.5 2区医学

Current Urology Reports Pub Date : 2024-10-08 DOI: 10.1007/s11934-024-01246-0

Mark A Moyad

{"title":"Rapid Lifestyle Recommendations to Improve Urologic, Heart and Overall Health.","authors":"Mark A Moyad","doi":"10.1007/s11934-024-01246-0","DOIUrl":"https://doi.org/10.1007/s11934-024-01246-0","url":null,"abstract":"Purpose of review: This literature review is intended to highlight recent correlations between urologic, heart and overall health by emphasizing healthy eating patterns, physical activity, alcohol minimization and tobacco elimination, healthy sleep, weight, cholesterol, blood sugar, blood pressure management, and mental health awareness.Recent findings: Meta-analyses, systematic reviews, and clinical studies espouse a unified message for prevention, reducing the risk of disease recurrence, progression, complementing conventional medical intervention efficacy, and mitigating treatment side effects. Limiting or eliminating alcohol consumption could be considered an independent recommendation and adding a mental health and miscellaneous (genetic risk and lifestyle, planetary health, HPV or other vaccination awareness, spirituality, etc.) category could allow for individualized educational opportunities, synergism appreciation, and self-improvement. Urologic healthcare professionals have the potential to strengthen the collective public health goal of improving the quality and quantity of the lives of patients able to adhere to these heart healthy recommendations.","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"10"},"PeriodicalIF":2.5,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia. 用于治疗良性前列腺增生症的前列腺导管和支架的最新进展。

IF 2.5 2区医学

Current Urology Reports Pub Date : 2024-10-07 DOI: 10.1007/s11934-024-01235-3

John Lama, Joshua Winograd, Alia Codelia-Anjum, Naeem Bhojani, Dean Elterman, Kevin C Zorn, Bilal Chughtai

{"title":"Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia.","authors":"John Lama, Joshua Winograd, Alia Codelia-Anjum, Naeem Bhojani, Dean Elterman, Kevin C Zorn, Bilal Chughtai","doi":"10.1007/s11934-024-01235-3","DOIUrl":"https://doi.org/10.1007/s11934-024-01235-3","url":null,"abstract":"Purpose of review: The prevalence of benign prostatic hyperplasia (BPH) is rising, however, current treatment options present severe complications and limit patient's quality of life. Accordingly, advancements in prostatic catheter and stent designs for use in treating lower urinary tract symptoms (LUTS) in BPH patients have largely expanded in the past five years and we aim to provide an exhaustive summary of recent outcomes.Recent findings: The dual dilation and paxlitaxel eluting Optilume BPH Catheter System enhances promise in catheter-based treatments, providing the longest sustained increase in max urinary flow rate and decrease in post-void residual volume compared to alternative MISTs. Additionally, use of iTiND, along with recent advancements in temporary (EXIME, Prodeon Urocross) and permanent (Zenflow Spring, Butterfly, and ClearRing) stent designs, have demonstrated rapid, lasting, and low-cost LUTS relief with sustained sexual function. Minimally invasive solutions that offer in-office treatment, rapid symptom relief, shorter recovery times, and preservation of sexual function hold great promise in improving outcomes in managing BPH patients with LUTS.","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"9"},"PeriodicalIF":2.5,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142380181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Implementation and Utility of the Da Vinci SP (Single Port) in Pediatric Urology. 达芬奇 SP（单孔）在小儿泌尿外科中的应用和效用。

IF 2.5 2区医学

Current Urology Reports Pub Date : 2024-10-03 DOI: 10.1007/s11934-024-01231-7

Lucas A Arney, Randall G Bissette, Jordan M Smith, Christopher E Bayne

{"title":"Implementation and Utility of the Da Vinci SP (Single Port) in Pediatric Urology.","authors":"Lucas A Arney, Randall G Bissette, Jordan M Smith, Christopher E Bayne","doi":"10.1007/s11934-024-01231-7","DOIUrl":"10.1007/s11934-024-01231-7","url":null,"abstract":"Purpose of review: Detail the evolution, utility, and future directions of the da Vinci SP® in pediatric urology, focusing on perioperative outcomes and intraoperative details.Recent findings: The SP has been safely and successfully utilized in various pediatric urological procedures, from pyeloplasty to nephroureterectomy to appendicovesicostomy. Reports indicate mixed operative times but similar hospital stays and postoperative outcomes compared to multiport (MP) robotic surgery. The learning curve for transitioning from MP to SP systems in pediatric patients appears manageable, though the smaller abdominal circumference in children poses a notable challenge. This review assumes that SP systems will primarily be acquired for adult services, not considering initial and ongoing costs to hospital systems. The SP serves as a complementary option, rather than a replacement, for MP robotic surgery in pediatric urology, offering potential advantages in specific scenarios. Cosmetic outcomes with the SP appear at least as favorable as MP surgery, but further research is needed. Future research should focus on patient-centered outcomes to optimize SP robotic surgery use in pediatric patients.","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"8"},"PeriodicalIF":2.5,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449982/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142364767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0